Sutton Wealth Advisors Inc. Vericel Corp Transaction History

Sutton Wealth Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$23.85 - $31.34 $13,594 - $17,863	-570 Closed	0 $0
Q4 2022 Nov 07, 2023	SELL	$17.65 - $27.37 $3,565 - $5,528	-202 Reduced 26.17%	570 $15 Million
Q3 2022 Nov 07, 2023	SELL	$22.62 - $32.54 $248 - $357	-11 Reduced 1.4%	772 $17.9 Million
Q2 2022 Nov 07, 2023	BUY	$22.88 - $39.45 $7,275 - $12,545	318 Added 68.39%	783 $19.7 Million
Q1 2022 Nov 07, 2023	BUY	$31.69 - $43.29 $14,387 - $19,653	454 Added 4127.27%	465 $17.8 Million
Q4 2021 Nov 07, 2023	SELL	$35.2 - $52.6 $19,008 - $28,404	-540 Reduced 98.0%	11 $432,000
Q3 2021 Nov 07, 2023	BUY	$46.35 - $59.75 $927 - $1,195	20 Added 3.77%	551 $26.9 Million
Q2 2021 Nov 07, 2023	BUY	$47.2 - $67.81 $25,063 - $36,007	531 New	531 $27.9 Million

293

50.7M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.18B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.